Literature DB >> 7259462

Five years experience with ceramic-metal-composite hip endoprostheses. II. Mechanical evaluations and improvements.

G Heimke, P Griss.   

Abstract

The results of the complete and detailed clinical evaluation are compared with the original design criteria. It is shown that most of them stood the test. Those aspects which did not meet the expectations are discussed in detail: The occurrence of very little and biologically tolerable wear during the initial running-in period will be further reduced by a considerable improvement of the material properties. The few cases of severe wear had been associated with clinically exceptional situations, the analysis of which allows for suggestions to avoid such situations. The material improvements and all other steps taken to increase the safety margin considerably against fractures of the ceramic ball are described in detail. In addition, the attention is paid to some necessary clinical precautions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259462     DOI: 10.1007/bf00632973

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0344-8444


  9 in total

1.  [Results of experimental tests and clinical application possibilities of aluminum oxide ceramics in alloarthroplasty].

Authors:  P Griss; H F von Andrian-Werburg; G Heimke; B Krempien; S Reipa; H J Hartung; H J Lauterbach
Journal:  Z Orthop Ihre Grenzgeb       Date:  1975-08

2.  Biological activity and histocompatibility of dense Al 2 O 3 -MgO ceramic implants in rats.

Authors:  P Griss; H V von Andrian-Werburg
Journal:  J Biomed Mater Res       Date:  1973

3.  Experimental analysis of ceramic-tissue interactions. A morphologic, fluoroescenseoptic, and radiographic study on dense alumina oxide ceramic in various animals.

Authors:  P Griss; B Krempien; H F von Andrian-Werburg; G Heimke; R Fleiner; T Diehm
Journal:  J Biomed Mater Res       Date:  1974

4.  [Total arthroplasty of the hip by fritted aluminum prosthesis. Experimental study and 1st clinical applications].

Authors:  P Boutin
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  1972 Apr-May

5.  [Is Al2O3 ceramic suitable for material used as sliding components in total joint replacements? (author's transl)].

Authors:  M Ungethüm; H J Refior
Journal:  Arch Orthop Unfallchir       Date:  1974

6.  [Alumina ceramic, a new biomaterial. Properties of the material and possible clinical range of application].

Authors:  G Heimke; P Griss; H F von Andrian-Werburg; B Krempien
Journal:  Arch Orthop Unfallchir       Date:  1974-05-28

7.  Five years experience with ceramic-metal-composite hip endoprostheses. I. clinical evaluation.

Authors:  P Griss; G Heimke
Journal:  Arch Orthop Trauma Surg       Date:  1981

8.  Morphological and biomechanical aspects of Al2O3 ceramic joint replacement. Experimental results and design considerations for human endoprostheses.

Authors:  P Griss; G Heimke; H Von Andrian-Werburg; B Krempien; S Reipa; H J Lauterbach; H J Hartung
Journal:  J Biomed Mater Res       Date:  1975-07

9.  Tissue reaction to ceramic implant material.

Authors:  J Harms; E Mäusle
Journal:  J Biomed Mater Res       Date:  1979-01
  9 in total
  5 in total

1.  Five years experience with ceramic-metal-composite hip endoprostheses. I. clinical evaluation.

Authors:  P Griss; G Heimke
Journal:  Arch Orthop Trauma Surg       Date:  1981

2.  The bonding of glass ceramics to bone.

Authors:  T Kitsugi; T Yamamuro; T Nakamura; T Kokubo
Journal:  Int Orthop       Date:  1989       Impact factor: 3.075

3.  How safe are ceramic heads as hip endoprostheses? A series of three head fractures within 3 months.

Authors:  A Burckhardt; C Berberat
Journal:  Arch Orthop Trauma Surg       Date:  1993       Impact factor: 3.067

Review 4.  [The problem of fractures of ceramic heads. What should be done?].

Authors:  H R Dürr
Journal:  Orthopade       Date:  2009-08       Impact factor: 1.087

5.  Third-generation pure alumina and alumina matrix composites in total hip arthroplasty: What is the evidence?

Authors:  Didier Hannouche; Matthieu Zingg; Hermes Miozzari; Remy Nizard; Anne Lübbeke
Journal:  EFORT Open Rev       Date:  2018-01-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.